Identifikasi Drug Related Problems (DRPs) pasien diabetes mellitus tipe 2 yang terkonfirmasi Covid-19
DOI:
10.29303/sjp.v4i1.218Downloads
Abstract
Drug Related Problems (DRPs) are events or circumstances related to drug therapy that actually or have the potential to interfere with the desired therapeutic outcome. This study aims to identify the incidence of DRPs in patients with type 2 diabetes mellitus who are confirmed to have Covid-19. This research is a type of observational research with a cross sectional design. Data collection was carried out retrospectively by tracing patient medical record data. The number of patients who met the researcher’s inclusion criteria was 125 patients and on average each patient had DRPs. The categories of DRPs that occurred were indications without drugs for 57 patients (45,6%), drugs without indications for 11 patients (8,8%), inappropriate drug selection for 45 patients (36%), inadequate doses for 28 patients (22,4%), overdosage in 46 patients (36,8%), and drug interactions in 88 patients (70,4%)
Keywords:
Diabetes mellitus type 2, Covid-19, Drug Related ProblemsReferences
Belice, T., & Demir, I. (2020). The gender differences as a risk factor in diabetic patients with Covid-19, 12 (6). 10.18502/ijm.v12i6.5038
Bergamaschi, G., Borrelli de Andreis, F., Aronico, N., Lenti, M. V., Barteselli, C., Merli, S., Pellegrino, I., Coppola, L., Cremonte, E. M., Croce, G., Mordà , F., Lapia, F., Ferrari, S., Ballesio, A., Parodi, A., Calabretta, F., Ferrari, M. G., Fumoso, F., Gentile, A., Stefani, D. (2021). Anemia in patients with Covid-19: pathogenesis and clinical significance. Clinical and Experimental Medicine, 21 (2), 239–246. https://doi.org/10.1007/s10238-020-00679-4
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S., & Hu, D. (2020). Diabetes is a risk factor for the progression and prognosis of Covid-19. Diabetes/Metabolism Research and Reviews, 36 (7). https://doi.org/10.1002/dmrr.3319
Hanutami, B., & Dandan, K. L. (2019). Identifikasi potensi interaksi antar obat pada resep umum di apotek kimia farma 58 kota bandung bulan april 2019. Farmaka, 17 (2), 57-64. https://doi.org/10.24198/jf.v17i2.22956
International Diabetes Federation. (2019). 463 million people living with diabetes. IDF Diabetes Atlas
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Narva, A. S., & Ortiz, E. (2014). 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). In JAMA (Vol. 311, Issue 5, pp. 507–520). American Medical Association. https://doi.org/10.1001/jama.2013.284427
Karyono, D. R., & Wicaksana, A. L. (2020). Current prevalence, characteristics, and comorbidities of patients with Covid-19 in Indonesia. Journal of Community Empowerment for Health, 3 (2), 77. https://doi.org/10.22146/jcoemph.57325
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016). Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. In Endocrine Reviews, 37 (3), 278-316. Endocrine Society. https://doi.org/10.1210/er.2015-1137
Kautzky-Willer, A. (2021). Does diabetes mellitus mitigate the gender gap in Covid-19 mortality? European Journal of Endocrinology, 185 (5), 13–17. https://doi.org/10.1530/EJE-21-0721
Kemenkes RI. (2021). Situasi indonesia 2 peta situasi di indonesia CFR dan recovery rate. https://infeksiemerging.kemkes.go.id
Korytkowski, M., Antinori-Lent, K., Drincic, A., Hirsch, I. B., Mcdonnell, M. E., Rushakoff, R., Muniyappa, R.,& Korytkowski, M. T. (2020). A Pragmatic Approach to Inpatient Diabetes Management during the Covid-19 Pandemic. 10.1210/clinem/dgaa342.
Mantovani, A., Byrne, C. D., Zheng, M. H., & Targher, G. (2020). Diabetes as a risk factor for greater Covid-19 severity and in-hospital death: A meta-analysis of observational studies. Nutrition, Metabolism and Cardiovascular Diseases, 30 (8), 1236–1248. https://doi.org/10.1016/j.numecd.2020.05.014
Mordarska, K., & Godziejewska-Zawada, M. (2017). Diabetes in the elderly. In Przeglad Menopauzalny, 16 (2), 38–43. Termedia Publishing House Ltd. https://doi.org/10.5114/pm.2017.68589
Pasquel, F. J., Fayfman, M., & Umpierrez, G. E. (2019). Debate on Insulin vs Non-insulin Use in the Hospital Setting-Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes? In Current Diabetes Reports, 19 (9), 65. https://doi.org/10.1007/s11892-019-1184-8
Peng, M., He, J., Xue, Y., Yang, X., Liu, S., & Gong, Z. (2021). Role of Hypertension on the Severity of Covid-19: A Review. 10.1097/FJC.0000000000001116
Sardu, C., D’Onofrio, N., Balestrieri, M. L., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Paolisso, G., &
Marfella, R. (2020). Outcomes in patients with hyperglycemia affected by Covid-19 : can we do more on glycemic control?. Diabetes Care, 43 (7), 1408-1415. 10.2337/dc20-0723
Wibisono, S., Soetmadji, D. W., Pranoto, A., Mardianto., Shahab, A., Karimi, J., Taringan, T. J. E., Pemanyun, T. G. D., Pramono, R. B., Fajari, N. M. (2021). Pedoman Petunjuk Praktis Terapi Insulin Pada Pasien Diabetes Mellitus. PB Perkeni.
World Health Organization. (2016). Global report on diabetes. WHO
Wu, J., Zhang, J., Sun, X., Wang, L., Xu, Y., Zhang, Y., Liu, X., & Dong, C. (2020). Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (Covid-19) infection. Diabetes, Obesity and Metabolism, 22 (10), 1907-1914. 10.1111/dom.141051054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and riskfactors for mortality of adult inpatients with Covid-19 in wuhan, china : a retrospective cohort study. The Lancet, 395 (10229), 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in china, 2019. New England Journal of Medicine, 382 (8), 727-733. 10.1056/NEJMoa2001017
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Sasambo Journal of Pharmacy (SJP), agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Lisensi Creative Commons Atribusi 4.0 Internasional. This license allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Sasambo Journal of Pharmacy
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
